Replimune Group Inc (NASDAQ: REPL) is 42.47% higher on its value in year-to-date trading and has touched a low of $4.92 and a high of $17.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The REPL stock was last observed hovering at around $11.66 in the last trading session, with the day’s gains setting it 0.35%.
Currently trading at $12.01, the stock is -7.08% and -1.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.41 million and changing 3.00% at the moment leaves the stock 25.43% off its SMA200. REPL registered 56.79% gain for a year compared to 6-month gain of 41.29%. The firm has a 50-day simple moving average (SMA 50) of $12.1674 and a 200-day simple moving average (SMA200) of $9.560175.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 9.68% loss in the last 1 month and extending the period to 3 months gives it a 10.08%, and is -1.72% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.08% over the week and 7.13% over the month.
Replimune Group Inc (REPL) has around 331 employees, a market worth around $904.84M and $0.00M in sales. Distance from 52-week low is 144.11% and -29.35% from its 52-week high. The company has generated returns on investments over the last 12 months (-46.96%).
The EPS is expected to grow by 11.58% this year
212.0 institutions hold shares in Replimune Group Inc (REPL), with institutional investors hold 96.21% of the company’s shares. The shares outstanding are 68.39M, and float is at 61.38M with Short Float at 9.10%. Institutions hold 92.17% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 10.05 million shares valued at $90.41 million. The investor’s holdings represent 15.0899 of the REPL Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 9.24 million shares valued at $83.13 million to account for 13.8742 of the shares outstanding. The other top investors are REDMILE GROUP, LLC which holds 5.56 million shares representing 8.3553 and valued at over $50.06 million, while FCPM III SERVICES B.V. holds 7.3103 of the shares totaling 4.87 million with a market value of $43.8 million.
Replimune Group Inc (REPL) Insider Activity
The most recent transaction is an insider sale by Patel Sushil, the company’s Chief Executive Officer. SEC filings show that Patel Sushil sold 10,000 shares of the company’s common stock on Dec 16 ’24 at a price of $12.42 per share for a total of $0.12 million. Following the sale, the insider now owns 0.2 million shares.
Still, SEC filings show that on Nov 18 ’24, Xynos Konstantinos (Chief Medical Officer) disposed off 7,246 shares at an average price of $10.78 for $78112.0. The insider now directly holds 109,885 shares of Replimune Group Inc (REPL).
